This study is currently not recruiting participants.

A Phase 2 Multicenter Randomized Placebo-controlled Double-blind Study to Evaluate the Efficacy and Safety of ALLN-177 Treatment Over 28 Days in Patients with Secondary Hyperoxaluria and Kidney Stones - 0000713

Study on the Effect of Investigational Medication on Health Conditions

Not Recruiting
100 years or below
All
Phase N/A
1 Location

Brief description of study.

The purpose of this study is to learn more about the effect of an investigational drug called ALLN-177.

Detailed description of study

The purpose of this study is to learn more about the effect of an investigational drug called ALLN-177.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: hyperoxaluria
  • Age: 100 years or below
  • Gender: All

This study investigates the effect of an investigational medication on certain health conditions. The purpose is to understand how the investigational medication works in the body and its potential impact on the condition being studied.

Participants in the study will undergo specific procedures to monitor the effects of the investigational medication. These may include regular health check-ups, blood tests, and other assessments to gather data on the medication's effects.

  • Who can participate: Participants must be within the age range of 18 to 65 and have a diagnosis of the specific health condition being studied. Additional eligibility criteria may include stable medication usage and no history of allergic reactions to similar medications.
  • Study details: Participants will receive either the investigational medication or a placebo. A placebo is an inactive substance that looks like the investigational medication but does not contain any medicine.
Updated on 19 Feb 2024. Study ID: 1510567780

Interested in the study?

Select a study center that’s convenient for you, and get in touch with the study team.

Connect with the study team